Den europeiske union - norsk - EMA (European Medicines Agency)

theramex ireland limited - teriparatide - osteoporose - kalsiumhomeostase - livogiva is indicated in adults. behandling av osteoporose hos postmenopausale kvinner og hos menn med økt risiko for brudd. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures have been demonstrated. behandling av osteoporose assosiert med vedvarende systemisk glukokortikoid terapi hos kvinner og menn med økt risiko for brudd.

Den europeiske union - norsk - EMA (European Medicines Agency)

accord healthcare s.l.u. - teriparatide - osteoporose - kalsiumhomeostase - sondelbay is indicated in adults. behandling av osteoporose hos postmenopausale kvinner og hos menn med økt risiko for brudd. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures have been demonstrated. behandling av osteoporose assosiert med vedvarende systemisk glukokortikoid terapi hos kvinner og menn med økt risiko for brudd.

Den europeiske union - norsk - EMA (European Medicines Agency)

theramex ireland limited - abaloparatide - osteoporosis, postmenopausal; osteoporosis - kalsiumhomeostase - behandling av osteoporose hos postmenopausale kvinner med økt risiko for brudd.

Den europeiske union - norsk - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - teriparatide - osteoporosis; osteoporosis, postmenopausal - kalsiumhomeostase - teriparatide sun is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.

Den europeiske union - norsk - EMA (European Medicines Agency)

strides pharma (cyprus) limited - teriparatide - osteoporosis; osteoporosis, postmenopausal - kalsiumhomeostase - kauliv is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.

Den europeiske union - norsk - EMA (European Medicines Agency)

instituto grifols, s.a. - human fibrinogen, human trombin - hemostase, kirurgisk - antihemoragika - støttende behandling i voksne der standard kirurgiske teknikker er ikke nok:for forbedring av haemostasisas sutur støtte i karkirurgi.